Search Results - "González, Lázaro Gil"
-
1
Evaluation in Mice of the Immunogenicity of a Tetravalent Subunit Vaccine Candidate Against Dengue Virus Using Mucosal and Parenteral Immunization Routes
Published in Viral immunology (01-06-2017)“…Our group has developed a subunit vaccine candidate against Dengue virus (DENV) based on two different viral regions, the domain III of the envelope protein…”
Get more information
Journal Article -
2
Screening for immune response against Dengue virus in Vietnamese non‐human primates: implications for vaccine developers
Published in Clinical & translational immunology (01-03-2017)“…One of the major problems faced for the development of a vaccine against Dengue virus is the lack of a suitable animal model. Although non‐human primates do…”
Get full text
Journal Article -
3
Comparative proteomic analysis of growth hormone secretagogue A233 treatment of murine macrophage cells J774A.2 indicates it has a role in antiviral innate response
Published in Biochemistry and biophysics reports (01-03-2016)“…Growth hormone secretagogues (GHS), among other factors, regulate the release of GH. The biological activity of the secretagogue peptide A233 as a promoter of…”
Get full text
Journal Article -
4
THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets
Published in PloS one (14-12-2022)“…Fc gamma receptors (FcγRs) are critical effector receptors for immunoglobulin G (IgG) antibodies. On macrophages, FcγRs mediate multiple effector functions,…”
Get full text
Journal Article -
5
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice
Published in Journal for immunotherapy of cancer (15-03-2024)“…BackgroundIn a prior report, we detailed the isolation and engineering of a bispecific killer cell engager, referred to as BiKE:E5C1. The BiKE:E5C1 exhibits…”
Get full text
Journal Article -
6
Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice
Published in The Journal of immunology (1950) (15-05-2024)“…Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low platelet counts primarily due to antiplatelet autoantibodies. Anti-D is a…”
Get full text
Journal Article -
7
Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression
Published in Blood (29-02-2024)“…•AMIS-inducing antibodies trigger in vivo RBC antigen and membrane loss independent of clearance.•AMIS-inducing antibodies, including anti-D, trigger in vitro…”
Get full text
Journal Article -
8
Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice
Published in International immunology (01-10-2009)“…Virus-like particles are a highly effective type of subunit vaccine that mimics the overall structure of virus particles without containing infectious genetic…”
Get full text
Journal Article -
9
Serum from half of patients with immune thrombocytopenia triggers macrophage phagocytosis of platelets
Published in Blood advances (25-07-2023)“…•Incubation of ITP serum with normal donor platelets triggered platelet uptake via macrophage phagocytosis for sera from half of the patients with…”
Get full text
Journal Article -
10
Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
Published in Blood advances (25-07-2023)“…Humoral antiplatelet factors, such as autoantibodies, are thought to primarily clear platelets by triggering macrophage phagocytosis in immune thrombocytopenia…”
Get full text
Journal Article -
11
Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP
Published in Blood advances (23-04-2024)“…•Human FcγRIII monovalent blocking as a 1-armed antibody or albumin fusion protein are effective in a humanized model of ITP.•The monovalent albumin fusion…”
Get full text
Journal Article -
12
Elucidating the FC Receptor and Platelet Activation Factor -Driven Inflammatory Consequences of AntiRBC Antibody Therapy in 8
Published in European journal of rheumatology (11-05-2024)Get full text
Journal Article -
13
Elucidating the FC Receptor and Platelet Activation Factor -Driven Inflammatory Consequences of AntiRBC Antibody Therapy in 8
Published in European journal of rheumatology (01-05-2024)Get full text
Journal Article -
14
THP-1 cells transduced with CD16A utilize Fc[gamma] receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets
Published in PloS one (14-12-2022)“…Fc gamma receptors (Fc[gamma]Rs) are critical effector receptors for immunoglobulin G (IgG) antibodies. On macrophages, Fc[gamma]Rs mediate multiple effector…”
Get full text
Journal Article -
15
-
16